Detalles de la búsqueda
1.
Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation.
Blood
; 134(11): 892-899, 2019 09 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31270102
2.
Timing of Post-Transplantation Cyclophosphamide Administration in Haploidentical Transplantation: A Comparative Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 26(10): 1915-1922, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32645444
3.
Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for T Cell Acute Lymphoblastic Leukemia: A Report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party.
Biol Blood Marrow Transplant
; 26(5): 936-942, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31926364
4.
Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 25(11): 2167-2171, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31284069
5.
Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 25(3): 522-528, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30408564
6.
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis.
Haematologica
; 104(9): 1782-1788, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30733269
7.
Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT.
Br J Haematol
; 182(3): 418-422, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29808926
8.
T-cell replete haploidentical stem cell transplantation attenuates the prognostic impact of FLT3-ITD in acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Am J Hematol
; 93(6): 736-744, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29498106
9.
Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group.
Clin Infect Dis
; 65(11): 1819-1828, 2017 Nov 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-29020364
10.
Centre characteristics and procedure-related factors have an impact on outcomes of allogeneic transplantation for patients with CLL: a retrospective analysis from the European Society for Blood and Marrow Transplantation (EBMT).
Br J Haematol
; 178(4): 521-533, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28589551
11.
Minimal residual disease detectable by quantitative assessment of WT1 gene before allogeneic stem cell transplantation in patients in first remission of acute myeloid leukemia has an impact on their future prognosis.
Clin Transplant
; 27(1): E21-9, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23231003
12.
Prognostic impact of DNMT3A mutations in patients with intermediate cytogenetic risk profile acute myeloid leukemia.
Eur J Haematol
; 88(2): 128-35, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21967546
13.
Impact of the Addition of Antithymocyte Globulin to Post-Transplantation Cyclophosphamide in Haploidentical Transplantation with Peripheral Blood Compared to Post-Transplantation Cyclophosphamide Alone in Acute Myelogenous Leukemia: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Transplant Cell Ther
; 28(9): 587.e1-587.e7, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35714906
14.
Total body irradiation plus fludarabine versus thiotepa, busulfan plus fludarabine as a myeloablative conditioning for adults with acute lymphoblastic leukemia treated with haploidentical hematopoietic cell transplantation. A study by the Acute Leukemia Working Party of the EBMT.
Bone Marrow Transplant
; 57(3): 399-406, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35031709
15.
Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the EBMT.
Bone Marrow Transplant
; 57(4): 562-571, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35079140
16.
WT1 Gene Expression in Peripheral Blood Before and After Allogeneic Stem Cell Transplantation is a Clinically Relevant Prognostic Marker in AML - A Single-center 14-year Experience.
Clin Lymphoma Myeloma Leuk
; 21(2): e145-e151, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33160932
17.
Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT.
Blood Cancer J
; 11(5): 88, 2021 05 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33980810
18.
Post-transplantation cyclophosphamide GvHD prophylaxis after hematopoietic stem cell transplantation from 9/10 or 10/10 HLA-matched unrelated donors for acute leukemia.
Leukemia
; 35(2): 585-594, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32409688
19.
Determinants of survival in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation.
Leukemia
; 35(1): 215-224, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32286544
20.
Allogeneic stem cell transplantation for patients with refractory anaemia with matched related and unrelated donors: delay of the transplant is associated with inferior survival.
Br J Haematol
; 146(6): 627-36, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19604243